Company Intelligence Profile
Cyclops Medtech Private Limited
Cyclops Medtech is a Bengaluru-based medical-devices company building vestibular (balance-disorder) assessment and rehabilitation systems.
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
Company Identity
Confirmed| Registered name | Cyclops Medtech Private Limited |
|---|---|
| CIN | U74900KA2015PTC078575 |
| PAN | AAFCC9247D (Source: Tofler only — TheCompanyCheck listed PAN as "not provided"; treat as partial/single-source) |
| Status | Active (Private Limited Company), Unlisted |
| Listing | No — unlisted private limited company |
| Incorporated | 29 January 2015 (Source: Tofler, TheCompanyCheck — agree) |
| ROC | RoC Karnataka (Bangalore) (Source: Tofler, TheCompanyCheck — agree) |
| Sector (NIC) | Healthcare / healthtech — medical devices for vestibular (balance) disorder diagnosis and rehabilitation; TheCompanyCheck classifies broad activity as "hospital and medical care activities." Precise NIC code: not obtained. |
| Registered address | No. 82, Swamy Vivekananda Road, 2nd Cross, Narayana Nagar, 1st Block, Kanakapura Road, Doddakallasandra, Municipal Corporation Layout, Bengaluru, Karnataka – 560062 (Source: Tofler, TheCompanyCheck — agree; matches company website contact address) |
| Authorized capital | ₹5.0 Crore (Source: Tofler, TheCompanyCheck — agree) |
| Paid-up capital | ₹1.57 Lakh (Issued & Subscribed also ₹1.57 Lakh) (Source: Tofler, TheCompanyCheck — agree) |
Business Overview
Confirmed- Cyclops Medtech is a Bengaluru-based medical-devices company building vestibular (balance-disorder) assessment and rehabilitation systems
- Flagship products per the official site (cyclopsmedtech.com): BalancEye VOG (videonystagmography), BalancEye vHIT (video head impulse test), BalancEye VRT (VR-based vestibular rehabilitation), and Postura (stabilometry / smart balance board)
- The company states its devices are used across neurotology, neurology, physical therapy, audiology and ophthalmology, reaching 900+ clinics/hospitals in 14 countries with 1.5 million+ tests/therapies delivered (company self-reported claim, not independently verified)
- Team is described as ~40 people across medical, scientific, engineering and business functions
- Source: cyclopsmedtech.com (official site)
Directors
Partial / conflictingPer Tofler (names + DINs) and corroborated by name/appointment-date match on TheCompanyCheck:
| Name | DIN | Role | Appointed |
|---|---|---|---|
| Ravi Chandran Nayar | 07043276 | Director/Co-founder Chief Scientific Officer per company site, appointed 29 Jan 2015 | 29 Jan 2015 |
| Dorasala Rammanna Srinivas | 07043290 | Director, appointed 29 Jan 2015 | 29 Jan 2015 |
| Niranjan Mysore Subbarao | 03032895 | Director/Co-founder CEO per company site, appointed 29 Jan 2015 | 29 Jan 2015 |
| Chandanmal Pukhraj Bothra | 00023108 | Nominee Director, appointed 09 Jul 2018 | 09 Jul 2018 |
Financials
Partial / conflictingConflicting-period, partially locked data:
| TheCompanyCheck | FY2023 (year ended 31 Mar 2023) Revenue ₹4.89 Crore, +19.41% YoY. EBITDA/PAT figures shown as "locked in full report" (paywalled). Employees ~25 (Mar 2024) |
|---|---|
| Tofler | shows FY2022 percentage changes only (paywalled absolutes): Total Revenue +74.06% YoY, EBITDA +180.54%, Net Profit +760.5%, Net Worth +16.81%, Borrowings −100%, Total Assets +24.16%. Ratios for FY2022: Operating Margin 6.36%, Net Profit Margin 14.14%, ROE 12.44%, ROCE 10.76%, Debt/Equity 0.0 |
No absolute EBITDA/PAT/net-worth/borrowings figures were obtainable from free-tier sources for either FY. Presumed standalone (no consolidation indicated for a single-entity private company; not explicitly stated by either source). Status: partial.
Funding
Partial / conflicting- No funding-round press coverage found on Entrackr or Inc42 (searched, zero results for "Cyclops Medtech")
- However, the company's own website lists "Nokha Holdings" and "Unitus Ventures" as organizational board representatives, strongly implying both have taken an equity/board position — but no round name, amount, date, or valuation could be confirmed from any source
- Status: partial (investor identities plausible from primary-source website
- deal terms not obtained)
Charges / Loans
Confirmed- Confirmed by two sources (Tofler, TheCompanyCheck): One open charge — Lender/Charge holder: HDFC Bank Limited
- Amount: ₹0.70 Crore (₹70 Lakh)
- Date created/modified: 12 October 2023
- Status: Open (not satisfied)
- No other charges (satisfied or open) reported on either source
Competitors
Partial / conflictingNot source-confirmed via a named competitor list (no analyst/press comparison found); based on product-category knowledge (vestibular/balance-disorder diagnostic and rehabilitation devices — VOG, vHIT, VRT-based vestibular rehab, posturography), plausible peers are:
- Interacoustics (Denmark, part of Demant) — large, global scale, vestibular/audiology diagnostics
- Natus Medical / Otometrics — large, global scale, ENG/VNG and balance systems
- Micromedical Technologies (Interacoustics-owned, US) — mid-large scale, VNG/rotary chair systems
- Bertec Corporation (US) — mid scale, posturography/balance-assessment platforms
- Trivitron Healthcare (India) — large diversified Indian medtech, broader portfolio (not vestibular-specialist but an Indian medtech peer/comparator)
- Meril Life Sciences (India) — large diversified Indian medtech, broader portfolio (comparator only)
Treat this list as directional/category-inferred, not a verified "who competes directly" roster.
Frequently Asked Questions
What does Cyclops Medtech Private Limited do?
What is the CIN of Cyclops Medtech Private Limited?
Where is Cyclops Medtech Private Limited registered?
When was Cyclops Medtech Private Limited incorporated?
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.
